"10.1371_journal.pone.0150213","plos one","2016-03-01T00:00:00Z","Akira Higuchi; Hiroko Toriniwa; Tomoyoshi Komiya; Tetsuo Nakayama","Kitasato-Daiichi Sankyo Vaccine, Division of Vaccine Production, Kitamoto City, Saitama Prefecture, 364–0026, Japan; Kitasato-Daiichi Sankyo Vaccine, Division of Vaccine Development, Kitamoto City, Saitama Prefecture, 364–0026, Japan; Kitasato Institute of Life Sciences, Laboratory of Viral Infection, Tokyo, 108–8641, Japan","Conceived and designed the experiments: TN. Performed the experiments: AH HT TN. Analyzed the data: TK TN. Contributed reagents/materials/analysis tools: TN. Wrote the paper: TN. Performed the present experiments during his master course: AH. Performed the detection of NT and EIA antibodies against JEV: HT TK. Developed measles vaccine vector and organized the study and prepared manuscript: TN.","On behalf of all co-authors, the following competing interests are declared: TN had research funding from Daiichi Sankyo. AH is an employee of Kitasato-Daiichi Sankyo Vaccine, Division of Vaccine Production. HT and TK are staff members of Kitasato-Daiichi Sankyo Vaccine, Division of Vaccine Development. Daiichi Sankyo provided JEV vaccine strain. There are no patents, products in development or marketed products to declare. This did not alter the adherence to all the PLOS ONE policies on sharing data and materials.","2016","03","Akira Higuchi","AH",4,TRUE,1,3,2,1,TRUE,FALSE,FALSE,0,NA,FALSE
